Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter
- 28 September 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (41) , 4787-4794
- https://doi.org/10.1038/sj.onc.1203831
Abstract
The tumor suppressor p53 plays a pivotal role in the cellular response to DNA damage as it controls DNA repair, cell cycle arrest and apoptosis. We studied the autoregulation of human p53 gene transcription in colon cancer cell lines. Wild-type p53 has been shown to autoregulate its own transcription either positively or negatively and probably in a cell-type-specific manner. Indeed, a p53 binding site has been described in the human and murine p53 promoters, but a direct binding of wild-type p53 protein to this site has never been reported. In this study, we demonstrated a transactivation of human p53 promoter by wild-type p53 in human colon cancer cells. We identified in the human p53 promoter a novel potential p53-responsive element that binds wild-type p53. Moreover, wild-type p53 protein transactivated a reporter plasmid containing a luciferase gene driven by a minimal promoter harboring this p53 binding site. Finally, as the p53 promoter contains an NF-kappaB binding site, we demonstrated an additive effect when NF-kappaB subunits and p53 protein combined to transactivate the human p53 promoter.Keywords
This publication has 46 references indexed in Scilit:
- Role of NF-κB in p53-mediated programmed cell deathNature, 2000
- Twenty years of p53 research: structural and functional aspects of the p53 proteinOncogene, 1999
- Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/MaxOncogene, 1999
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Nuclear factor – κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drugOncogene, 1998
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997
- Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific MannerDNA and Cell Biology, 1995
- p53, guardian of the genomeNature, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991